Emster Kurt Von - Net Worth and Insider Trading
Emster Kurt Von Net Worth
The estimated net worth of Emster Kurt Von is at least $55 Million dollars as of 2024-11-13. Emster Kurt Von is the Director of CymaBay Therapeutics Inc and owns about 1,707,326 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $55 Million. Details can be seen in Emster Kurt Von's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Emster Kurt Von has not made any transactions after 2015-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Emster Kurt Von
Emster Kurt Von Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Emster Kurt Von owns 1 companies in total, including CymaBay Therapeutics Inc (CBAY) .
Click here to see the complete history of Emster Kurt Von’s form 4 insider trades.
Insider Ownership Summary of Emster Kurt Von
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2017-06-28 | director |
Emster Kurt Von Latest Holdings Summary
Emster Kurt Von currently owns a total of 1 stock. Emster Kurt Von owns 1,707,326 shares of CymaBay Therapeutics Inc (CBAY) as of August 14, 2015, with a value of $55 Million.
Latest Holdings of Emster Kurt Von
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBAY | CymaBay Therapeutics Inc | 2015-08-14 | 1,707,326 | 32.48 | 55,453,948 |
Holding Weightings of Emster Kurt Von
Emster Kurt Von Form 4 Trading Tracker
According to the SEC Form 4 filings, Emster Kurt Von has made a total of 0 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years. The most-recent trade in CymaBay Therapeutics Inc is the acquisition of 90,000 shares on August 14, 2015, which cost Emster Kurt Von around $242,100.
Insider Trading History of Emster Kurt Von
- 1
Emster Kurt Von Trading Performance
GuruFocus tracks the stock performance after each of Emster Kurt Von's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Emster Kurt Von is -35.53%. GuruFocus also compares Emster Kurt Von's trading performance to market benchmark return within the same time period. The performance of stocks bought by Emster Kurt Von within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Emster Kurt Von's insider trading performs compared to the benchmark.
Performance of Emster Kurt Von
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.13 | | | | | |
| Relative Return to S&P 500(%) | 13.62 | | | | | |
Emster Kurt Von Ownership Network
Ownership Network List of Emster Kurt Von
Ownership Network Relation of Emster Kurt Von
Emster Kurt Von Owned Company Details
What does CymaBay Therapeutics Inc do?
Who are the key executives at CymaBay Therapeutics Inc?
Emster Kurt Von is the director of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and General Counsel Paul T Quinlan .
CymaBay Therapeutics Inc (CBAY) Insider Trades Summary
Over the past 18 months, Emster Kurt Von made no insider transaction in CymaBay Therapeutics Inc (CBAY). Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 171,559 shares made by Charles Mcwherter , a net sale of 93,000 shares made by Paul T Quinlan , and a net sale of 52,442 shares made by Daniel Menold .
In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 481,646 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 481,646 shares.
CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
CymaBay Therapeutics Inc Insider Transactions
Emster Kurt Von Mailing Address
Above is the net worth, insider trading, and ownership report for Emster Kurt Von. You might contact Emster Kurt Von via mailing address: C/o Cymabay Therapeutics, Inc., 3876 Bay Center Place, Hayward Ca 94545.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
